IMC-003 (Immunofoco)

N/A

Report date: 2023/02/22 15:34:48

Base Information

Drug NameIMC-003 (Immunofoco)
Drug Alias NameIMC-003IMC-003（易慕峰）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsDigestive System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Immunofoco Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Immunofoco Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDigestive System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A